Not a rec. Just a heads up. I'm accumulating enough JNUG to trade intraday and short term upmoves IF it bounces.
Have not (yet) added to usual miners (eg, CDE AUY on this upmove).
Profit for Good Causes
JNUG touched 22.40 and rising thus far. For now, just short term, even intraday trading with add/sell.
At this point, JNUG as moved from 22.40 to 23.40.
We'll see if bounce continues.
'Coal left out in the cold with gold'...counting endlessly, ill-gotten gains (thru lies/harassment/manipulation)...
in the flames...
alone, except for tormentors,
May God pour His Powerful Graces on All...convert us to His Way of Peace, Joy, Agape to Overflowing
House of Gold and Mother of Mercy...'Pray for us sinners, now and at the hour of our death.'
VXX VXZ again extremely oversold. All eyes on Jackson Hole, it seems.
Real unemployment more than 90 million, and large quantities of new jobs are PART TIME.
That fact, plus the 30% to 50% increase in health insurance due to O'care, may help kill the consumer.
Small businesses, engine of new employment (as much as 80%) are being suffocated by hundreds of new and useless (corrupt, imo) regulations that help the huge corporate COMPETITORS.
That's how both D & R work AGAINST small business AND against 'We the People'...by crony capitalism AGAINST the li'l guy and the small business, source of independence and innovation.
Altho interim election years (non-Presidential cycle) are sometimes weaker (or correction) times, I'm expecting markets will look resplendent near election time.
Let's see if the Fed makes some more stock calls this time. They do call gold by dovish/bearish stance,,,all based on statistics that have been 'adjusted' over the years so they reflect less and less reality.
Lesh said gold has support at the April low of $1,270, which will be the next area to watch. “We’ll have to watch if it can stabilize here,” he said, adding if gold cannot, the next support is around $1,250.
Just as gold is testing some downside support, the U.S. dollar is testing its upper boundaries, and Lesh said the near-term rally may be getting a bit overdone. A backtrack by the dollar could help gold, too.
“We’re getting a bit overbought in the near-term. We’ll need to retrace, but I don’t know when that will be,” he said.
JNUG testing 200ma, but I did not yet add. IF support holds, I may add/trade for bounces. Yesterday JNUG had magnicent range for intraday trading, but my long term overweights have generally not been in precious metals mining...just JNUG now heavier (again) in trading portfolio v individual precious metals miners.
See daily candles on FXE at extremely oversold area.
That fact, plus oversold VXX VXZ, are a heads up to me re gold.jmo
now that is one of the sickest posts ever. there is nothing worse than a bible throwing hypocrite. perhaps you should think about the eternal Lake of Fire.
speaking of coal...who has the repertoire of a cockroach...
cockroaches have been around since the Mississippian...even before the Pennsylvanian coal beds
they and he are still trying to learn something new, perhaps...
before moving on...
ya' have to be patient with such as those...
May the 'black-coal' little heart(s) on this message board find Agape to overflowing, since,
"In My Father's house, there are many mansions."
No one would want a 'coal_porter' to be left out in the gold. Or even worse, in a room of eternal tortures, in flames. At least no one filled with Agape would desire that.
"Where your treasure is, there is your heart."
"You will seek me and find me when you seek me with all your heart." (Jeremiah)
"Take delight in the LORD, and he will give you the desires of your heart." (Psalms)
jmo n Agape to All~
For EDAP, that's comparing EDAP's Ablatherm to Sonablate (the US device that is considered greatly inferior by some MDs/urologists according to published comparisons...see the HIFU (ca) website video comparison by and MD and the pro/con comparison chart re imaging, efficacy, safety and other outcomes/evaluations. (Sonolith is not the device for prostate cancer, but for lithotripsy by EDAP-TMS.)
PRAN now at 2.1891 (+5%)
EDAP (laughing) loaded up with litigation that (in my opinion) will be dismissed, since not only is there no fraud on the part of EDAP, there appears to be some 'reasons' to consider possible 'conflict of interest' ??? by the panel ???? which will evaluate US product in a few months. EDAP hired respected company to guide through FDA approval process.
See deepcapture website to understand WHY WE DO NOT HAVE THE BENEFIT OF MANY SAFE AND EFFECTIVE PROCEDURES AND TREATMENTS IN THE US and WHY THEY ARE DELAYED. Ever wonder why so many natural remedies that are used worldwide are considered 'scams' in the US? Even those with magnificent research to support? Advocates eternally harassed? A threat to WHOM?
Who is taking care of 'turf' and greed rather than PATIENTS?
Thare are bashers/manipulators...but does 'someone(s)' pay them?
Follow Authentic Science Wherever It Leads
PRAN and others appear to be in the process of demonstrating that their approach to Huntington's Disease and to Alzheimer's may be CORRECT.
There is now more understanding WHY the placebo arm had UNPRECEDENTED IMPROVEMENT, which skewed the tiny trial.
Wise folks will check out that message board for posts by pivalde, interestingtome, pierreluke and many others, including an MD.
For EDAP, has FDA approval for Sonolith, lipotripsy device used all over the world.
Sought FDA approval for prostate with Ablatherm, but received obnoxious (and absurd, imo) smackdown. A competitor in the US eventually attempted an GREATLY INFERIOR (my opinion) product (ultrasound for prostate cancer): See Canadian website HIFU (ca) for video and pro/con comparing Ablatherm to Sonolith. Sonolith meeting with FDA still to come. EDAP Ablatherm safety and efficacy studies published. 40,000 patients worldwide. EU approved and RECOMMENDED.
EDAP's Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year Study
Third Long Term Study Published in 2013 Validates Ablatherm-HIFU as First Line Treatment of Prostate Cancer
Marc Oczachowski, Chief Executive Officer, concluded, "These are great long term results and it is extremely positive to see these publications in top tier journals. Corroboration of high 10 year rates for both cancer specific survival and freedom from metastases furthers Ablatherm-HIFU as a standard of care treatment for prostate cancer. It is positive to have this published as we move forward in the final stages of our FDA clinical trial."
SYN: 'SYN' lover from below a dollar, when it was called 'AEN.' Nice 17% upmove today.
NOT a rec to do anything but INDEPENDENT thinking.
thank you for yours, vcaritas, and also for the kind words...
we shall not let the coal dust get in our eyes...
as we attempt to follow the trails blazed by the Gandhis over the centuries and continents...
and perhaps lay out some new ones of our own...